Global Hepatitis B Vaccine (Recombinant) Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Hepatitis B Vaccine (Recombinant) by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Hepatitis B Vaccine (Recombinant) by Country/Region, 2017, 2022 & 2028

2.2 Hepatitis B Vaccine (Recombinant) Segment by Type

2.2.1 10mcg/0.5ml

2.2.2 10mcg/ml

2.3 Hepatitis B Vaccine (Recombinant) Sales by Type

2.3.1 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2017-2022)

2.3.2 Global Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Type (2017-2022)

2.3.3 Global Hepatitis B Vaccine (Recombinant) Sale Price by Type (2017-2022)

2.4 Hepatitis B Vaccine (Recombinant) Segment by Application

2.4.1 Newborn

2.4.2 Adult

2.5 Hepatitis B Vaccine (Recombinant) Sales by Application

2.5.1 Global Hepatitis B Vaccine (Recombinant) Sale Market Share by Application (2017-2022)

2.5.2 Global Hepatitis B Vaccine (Recombinant) Revenue and Market Share by Application (2017-2022)

2.5.3 Global Hepatitis B Vaccine (Recombinant) Sale Price by Application (2017-2022)

3 Global Hepatitis B Vaccine (Recombinant) by Company

3.1 Global Hepatitis B Vaccine (Recombinant) Breakdown Data by Company

3.1.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales by Company (2020-2022)

3.1.2 Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Company (2020-2022)

3.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue by Company (2020-2022)

3.2.1 Global Hepatitis B Vaccine (Recombinant) Revenue by Company (2020-2022)

3.2.2 Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Company (2020-2022)

3.3 Global Hepatitis B Vaccine (Recombinant) Sale Price by Company

3.4 Key Manufacturers Hepatitis B Vaccine (Recombinant) Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Hepatitis B Vaccine (Recombinant) Product Location Distribution

3.4.2 Players Hepatitis B Vaccine (Recombinant) Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Hepatitis B Vaccine (Recombinant) by Geographic Region

4.1 World Historic Hepatitis B Vaccine (Recombinant) Market Size by Geographic Region (2017-2022)

4.1.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue by Geographic Region

4.2 World Historic Hepatitis B Vaccine (Recombinant) Market Size by Country/Region (2017-2022)

4.2.1 Global Hepatitis B Vaccine (Recombinant) Annual Sales by Country/Region (2017-2022)

4.2.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue by Country/Region

4.3 Americas Hepatitis B Vaccine (Recombinant) Sales Growth

4.4 APAC Hepatitis B Vaccine (Recombinant) Sales Growth

4.5 Europe Hepatitis B Vaccine (Recombinant) Sales Growth

4.6 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Growth

5 Americas

5.1 Americas Hepatitis B Vaccine (Recombinant) Sales by Country

5.1.1 Americas Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2022)

5.1.2 Americas Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2022)

5.2 Americas Hepatitis B Vaccine (Recombinant) Sales by Type

5.3 Americas Hepatitis B Vaccine (Recombinant) Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Hepatitis B Vaccine (Recombinant) Sales by Region

6.1.1 APAC Hepatitis B Vaccine (Recombinant) Sales by Region (2017-2022)

6.1.2 APAC Hepatitis B Vaccine (Recombinant) Revenue by Region (2017-2022)

6.2 APAC Hepatitis B Vaccine (Recombinant) Sales by Type

6.3 APAC Hepatitis B Vaccine (Recombinant) Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Hepatitis B Vaccine (Recombinant) by Country

7.1.1 Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2022)

7.1.2 Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2022)

7.2 Europe Hepatitis B Vaccine (Recombinant) Sales by Type

7.3 Europe Hepatitis B Vaccine (Recombinant) Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Hepatitis B Vaccine (Recombinant) by Country

8.1.1 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2022)

8.1.2 Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2022)

8.2 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Type

8.3 Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Hepatitis B Vaccine (Recombinant)

10.3 Manufacturing Process Analysis of Hepatitis B Vaccine (Recombinant)

10.4 Industry Chain Structure of Hepatitis B Vaccine (Recombinant)

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Hepatitis B Vaccine (Recombinant) Distributors

11.3 Hepatitis B Vaccine (Recombinant) Customer

12 World Forecast Review for Hepatitis B Vaccine (Recombinant) by Geographic Region

12.1 Global Hepatitis B Vaccine (Recombinant) Market Size Forecast by Region

12.1.1 Global Hepatitis B Vaccine (Recombinant) Forecast by Region (2023-2028)

12.1.2 Global Hepatitis B Vaccine (Recombinant) Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Hepatitis B Vaccine (Recombinant) Forecast by Type

12.7 Global Hepatitis B Vaccine (Recombinant) Forecast by Application

13 Key Players Analysis

13.1 GSK

13.1.1 GSK Company Information

13.1.2 GSK Hepatitis B Vaccine (Recombinant) Product Offered

13.1.3 GSK Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GSK Main Business Overview

13.1.5 GSK Latest Developments

13.2 Merck

13.2.1 Merck Company Information

13.2.2 Merck Hepatitis B Vaccine (Recombinant) Product Offered

13.2.3 Merck Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Merck Main Business Overview

13.2.5 Merck Latest Developments

13.3 Sanofi Pasteur

13.3.1 Sanofi Pasteur Company Information

13.3.2 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Offered

13.3.3 Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanofi Pasteur Main Business Overview

13.3.5 Sanofi Pasteur Latest Developments

13.4 Dynavax Technologies

13.4.1 Dynavax Technologies Company Information

13.4.2 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Offered

13.4.3 Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Dynavax Technologies Main Business Overview

13.4.5 Dynavax Technologies Latest Developments

13.5 LG Life Sciences

13.5.1 LG Life Sciences Company Information

13.5.2 LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Offered

13.5.3 LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 LG Life Sciences Main Business Overview

13.5.5 LG Life Sciences Latest Developments

13.6 KM Biologics

13.6.1 KM Biologics Company Information

13.6.2 KM Biologics Hepatitis B Vaccine (Recombinant) Product Offered

13.6.3 KM Biologics Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 KM Biologics Main Business Overview

13.6.5 KM Biologics Latest Developments

13.7 Shenzhen Kangtai Biological Products

13.7.1 Shenzhen Kangtai Biological Products Company Information

13.7.2 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Offered

13.7.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Shenzhen Kangtai Biological Products Main Business Overview

13.7.5 Shenzhen Kangtai Biological Products Latest Developments

13.8 Serum Institute

13.8.1 Serum Institute Company Information

13.8.2 Serum Institute Hepatitis B Vaccine (Recombinant) Product Offered

13.8.3 Serum Institute Hepatitis B Vaccine (Recombinant) Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Serum Institute Main Business Overview

13.8.5 Serum Institute Latest Developments

14 Research Findings and Conclusion

Table 1. Hepatitis B Vaccine (Recombinant) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Hepatitis B Vaccine (Recombinant) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 10mcg/0.5ml

Table 4. Major Players of 10mcg/ml

Table 5. Global Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2022) & (K Units)

Table 6. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2017-2022)

Table 7. Global Hepatitis B Vaccine (Recombinant) Revenue by Type (2017-2022) & ($ million)

Table 8. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2017-2022)

Table 9. Global Hepatitis B Vaccine (Recombinant) Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2022) & (K Units)

Table 11. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2017-2022)

Table 12. Global Hepatitis B Vaccine (Recombinant) Revenue by Application (2017-2022)

Table 13. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application (2017-2022)

Table 14. Global Hepatitis B Vaccine (Recombinant) Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Hepatitis B Vaccine (Recombinant) Sales by Company (2020-2022) & (K Units)

Table 16. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Company (2020-2022)

Table 17. Global Hepatitis B Vaccine (Recombinant) Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Company (2020-2022)

Table 19. Global Hepatitis B Vaccine (Recombinant) Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Hepatitis B Vaccine (Recombinant) Producing Area Distribution and Sales Area

Table 21. Players Hepatitis B Vaccine (Recombinant) Products Offered

Table 22. Hepatitis B Vaccine (Recombinant) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Hepatitis B Vaccine (Recombinant) Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Geographic Region (2017-2022)

Table 27. Global Hepatitis B Vaccine (Recombinant) Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Hepatitis B Vaccine (Recombinant) Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Country/Region (2017-2022)

Table 31. Global Hepatitis B Vaccine (Recombinant) Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2022) & (K Units)

Table 34. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2017-2022)

Table 35. Americas Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2017-2022)

Table 37. Americas Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2022) & (K Units)

Table 38. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2017-2022)

Table 39. Americas Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2022) & (K Units)

Table 40. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2017-2022)

Table 41. APAC Hepatitis B Vaccine (Recombinant) Sales by Region (2017-2022) & (K Units)

Table 42. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2017-2022)

Table 43. APAC Hepatitis B Vaccine (Recombinant) Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Hepatitis B Vaccine (Recombinant) Revenue Market Share by Region (2017-2022)

Table 45. APAC Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2022) & (K Units)

Table 46. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2017-2022)

Table 47. APAC Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2022) & (K Units)

Table 48. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2017-2022)

Table 49. Europe Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2022) & (K Units)

Table 50. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2017-2022)

Table 51. Europe Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2017-2022)

Table 53. Europe Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2022) & (K Units)

Table 54. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2017-2022)

Table 55. Europe Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2022) & (K Units)

Table 56. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Hepatitis B Vaccine (Recombinant)

Table 66. Key Market Challenges & Risks of Hepatitis B Vaccine (Recombinant)

Table 67. Key Industry Trends of Hepatitis B Vaccine (Recombinant)

Table 68. Hepatitis B Vaccine (Recombinant) Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Hepatitis B Vaccine (Recombinant) Distributors List

Table 71. Hepatitis B Vaccine (Recombinant) Customer List

Table 72. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Hepatitis B Vaccine (Recombinant) Sales Market Forecast by Region

Table 74. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Hepatitis B Vaccine (Recombinant) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Hepatitis B Vaccine (Recombinant) Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Hepatitis B Vaccine (Recombinant) Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Hepatitis B Vaccine (Recombinant) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Hepatitis B Vaccine (Recombinant) Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Hepatitis B Vaccine (Recombinant) Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Hepatitis B Vaccine (Recombinant) Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share Forecast by Application (2023-2028)

Table 92. GSK Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors

Table 93. GSK Hepatitis B Vaccine (Recombinant) Product Offered

Table 94. GSK Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. GSK Main Business

Table 96. GSK Latest Developments

Table 97. Merck Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors

Table 98. Merck Hepatitis B Vaccine (Recombinant) Product Offered

Table 99. Merck Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 100. Merck Main Business

Table 101. Merck Latest Developments

Table 102. Sanofi Pasteur Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors

Table 103. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Product Offered

Table 104. Sanofi Pasteur Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 105. Sanofi Pasteur Main Business

Table 106. Sanofi Pasteur Latest Developments

Table 107. Dynavax Technologies Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors

Table 108. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Product Offered

Table 109. Dynavax Technologies Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 110. Dynavax Technologies Main Business

Table 111. Dynavax Technologies Latest Developments

Table 112. LG Life Sciences Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors

Table 113. LG Life Sciences Hepatitis B Vaccine (Recombinant) Product Offered

Table 114. LG Life Sciences Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 115. LG Life Sciences Main Business

Table 116. LG Life Sciences Latest Developments

Table 117. KM Biologics Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors

Table 118. KM Biologics Hepatitis B Vaccine (Recombinant) Product Offered

Table 119. KM Biologics Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 120. KM Biologics Main Business

Table 121. KM Biologics Latest Developments

Table 122. Shenzhen Kangtai Biological Products Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors

Table 123. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Product Offered

Table 124. Shenzhen Kangtai Biological Products Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 125. Shenzhen Kangtai Biological Products Main Business

Table 126. Shenzhen Kangtai Biological Products Latest Developments

Table 127. Serum Institute Basic Information, Hepatitis B Vaccine (Recombinant) Manufacturing Base, Sales Area and Its Competitors

Table 128. Serum Institute Hepatitis B Vaccine (Recombinant) Product Offered

Table 129. Serum Institute Hepatitis B Vaccine (Recombinant) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 130. Serum Institute Main Business

Table 131. Serum Institute Latest Developments

List of Figures

Figure 1. Picture of Hepatitis B Vaccine (Recombinant)

Figure 2. Hepatitis B Vaccine (Recombinant) Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Hepatitis B Vaccine (Recombinant) Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Hepatitis B Vaccine (Recombinant) Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Hepatitis B Vaccine (Recombinant) Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 10mcg/0.5ml

Figure 10. Product Picture of 10mcg/ml

Figure 11. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Type in 2021

Figure 12. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Type (2017-2022)

Figure 13. Hepatitis B Vaccine (Recombinant) Consumed in Newborn

Figure 14. Global Hepatitis B Vaccine (Recombinant) Market: Newborn (2017-2022) & (K Units)

Figure 15. Hepatitis B Vaccine (Recombinant) Consumed in Adult

Figure 16. Global Hepatitis B Vaccine (Recombinant) Market: Adult (2017-2022) & (K Units)

Figure 17. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Application (2017-2022)

Figure 18. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Application in 2021

Figure 19. Hepatitis B Vaccine (Recombinant) Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Company in 2021

Figure 21. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Geographic Region in 2021

Figure 23. Global Hepatitis B Vaccine (Recombinant) Sales Market Share by Region (2017-2022)

Figure 24. Global Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country/Region in 2021

Figure 25. Americas Hepatitis B Vaccine (Recombinant) Sales 2017-2022 (K Units)

Figure 26. Americas Hepatitis B Vaccine (Recombinant) Revenue 2017-2022 ($ Millions)

Figure 27. APAC Hepatitis B Vaccine (Recombinant) Sales 2017-2022 (K Units)

Figure 28. APAC Hepatitis B Vaccine (Recombinant) Revenue 2017-2022 ($ Millions)

Figure 29. Europe Hepatitis B Vaccine (Recombinant) Sales 2017-2022 (K Units)

Figure 30. Europe Hepatitis B Vaccine (Recombinant) Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue 2017-2022 ($ Millions)

Figure 33. Americas Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2021

Figure 34. Americas Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2021

Figure 35. United States Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Hepatitis B Vaccine (Recombinant) Sales Market Share by Region in 2021

Figure 40. APAC Hepatitis B Vaccine (Recombinant) Revenue Market Share by Regions in 2021

Figure 41. China Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2021

Figure 48. Europe Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2021

Figure 49. Germany Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Hepatitis B Vaccine (Recombinant) Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Hepatitis B Vaccine (Recombinant) Revenue Market Share by Country in 2021

Figure 56. Egypt Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Hepatitis B Vaccine (Recombinant) Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Hepatitis B Vaccine (Recombinant) in 2021

Figure 62. Manufacturing Process Analysis of Hepatitis B Vaccine (Recombinant)

Figure 63. Industry Chain Structure of Hepatitis B Vaccine (Recombinant)

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles